-
Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.
Novel anti-inflammatory drug shows early promise in treating Long COVID cognitive symptoms, fatigue, PEM. The study looked at multiple endpoints and consulted with people living with the disease. Read more…
Recent articles
Get the latest Long COVID news and commentary
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Check out our weekly podcast, Still Here
Spotify
Apple Podcasts
PocketCasts
iHeartRadio
RSS
Policy & Advocacy
Science
-
Research updates, January 28
-
Long COVID is a smoldering threat to wildland firefighters
-
Finding an accepted Long COVID biomarker will be complicated. This blood test could give us answers.
-
Research updates, January 21
-
Immune system damage from COVID-19 is different from HIV/AIDS — but the advocacy has parallels
-
Research updates, January 14
Covid-19
Health
-
Long COVID inspired me to start an IACC case competition at my business school. Here’s how you can get involved.
-
Patricia Lockwood explores the depths of Long COVID in the new novel “Will There Ever Be Another You”
-
Letter to the editors: Concerns about California’s right-to-mask bill
-
Stop looking for a silver bullet. Start mixing the Long COVID cocktail.